| Literature DB >> 24091848 |
S Snauwaert1, G Verstichel1, S Bonte1, G Goetgeluk1, S Vanhee1, Y Van Caeneghem1, K De Mulder1, C Heirman2, H Stauss3, M H M Heemskerk4, T Taghon1, G Leclercq1, J Plum1, A W Langerak5, K Thielemans2, T Kerre1, B Vandekerckhove1.
Abstract
Peripheral blood T cells transduced with a tumor-specific T-cell receptor (TCR) face problems of auto-reactivity and lack of efficacy caused by cross-pairing of exogenous and endogenous TCR chains, as well as short term in vivo survival due to activation and growth factor-induced differentiation. We here studied an alternative strategy for the efficient generation of naive CD8(+) T cells with a single TCR. TCR-transduced human postnatal thymus-derived and adult mobilized blood-derived hematopoietic progenitor cells (HPCs) were differentiated to CD4(+)CD8(+) double-positive T cells using OP9-Delta-like 1 (OP9-DL1) cultures. Addition of the agonist peptide induced double positive cells to cross-present the peptide, leading, in the absence of co-stimulation, to cell cycle arrest and differentiation into mature CD8(+) T cells. Comprehensive phenotypic, molecular and functional analysis revealed the generation of naive and resting CD8(+) T cells through a process similar to thymic positive selection. These mature T cells show a near complete inhibition of endogenous TCRA and TCRB rearrangements and express high levels of the introduced multimer-reactive TCR. Upon activation, specific cytokine production and efficient killing of tumor cells were induced. Using this strategy, large numbers of high-avidity tumor-specific naive T cells can be generated from readily available HPCs without TCR chain cross-pairing.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24091848 DOI: 10.1038/leu.2013.285
Source DB: PubMed Journal: Leukemia ISSN: 0887-6924 Impact factor: 11.528